Day One Biopharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Day One Biopharmaceuticals, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pursuant to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
Day One Biopharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 2, 2025, to elect directors, ratify the appointment of its accounting firm, and vote on executive compensation.
NASDAQ
Day One Biopharmaceuticals, Inc. has filed a proxy statement with the Securities and Exchange Commission (SEC) pursuant to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
Day One Biopharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on May 23, 2024, to vote on director elections, auditor ratification, executive compensation, and the frequency of future executive compensation votes.